Experts’ position on durvalumab treatment for cholangiocarcinoma patients

Michał F. Kamiński, Nastazja Pilonis, Leszek Kraj, Maciej Kawecki, Tomasz Kubiatowski

Online first

Guidelines / Expert consensus

Fusion variants of the ALK gene — the key to modern therapy for patients with ALK-positive non-small-cell lung cancer

Kinga Winiarczyk, Dariusz M. Kowalski, Maciej Krzakowski

Online first

Review paper

Main risk factors for local recurrence in patients with cutaneous melanoma — single center study

Strahil Asenov Strashilov, Angel Danchev Yordanov, Vasil Dimitrov Nanev, Gancho Georgiev Kostov, Joana Ivanova Simeonova

Online first

Research paper

Improving outcomes in oral mucositis — emerging role of polaprezinc

Grzegorz Borowski, Maria Zasadzińska, Karolina Matuszewska, Adrian Bystroń

Online first

Review paper

Ivosidenib in treatment of patients with cholangiocarcinoma with IDH1 mutation — real-world data from a multicenter study

Bożena J. Cybulska-Stopa, Maciej Kawecki, Patrycja Szymańska, Piotr Duszyński, Zuzanna Borysiewicz, Marek Szwiec, Cieszymierz Gawiński, Agnieszka Czamańska, Bogumiła Galińska, Paulina Żukowska, Hanna Liberek, Aleksandra Chojnowska, Robert Dziura, Lucjan Wyrwicz, Maciej Krzakowski

Online first

Research paper

High-dose adaptive radiotherapy for inoperable breast cancer with skin invasion after failure of chemotherapy

Yukihiro Hama, Etsuko Tate

Online first

Research paper

Combination of docetaxel and irinotecan as a second-line treatment of metastatic gastric cancer: a phase II study

Reham Abdelaziz, Amira Hegazy, Ahmed Sohaib

Online first

Research paper

Exploring the unknown: rare primary brain tumors — diagnosis and treatment

Elżbieta Dziedzic, Joanna Turkiewicz, Jolanta Zapędowska, Andrzej Kawecki

Online first

Review paper

Where there’s smoke, there’s fire — a brief report on skin malignancy incidence in renal, heart, and liver transplant recipients in Poland

Wojciech M. Wysocki, Aleksandra Kulbat

Online first

Review paper

Does toxicity of cyclin-dependent kinase 4/6 inhibitor predict treatment response in metastatic hormone-positive breast cancer patients?

Burcu Gulbagci, Ayşe Demirci, Abdüssamet Çelebi, Sedat Tarık Fırat, Ivo Gökmen, Irem Uğurlu, Huri Tilla Ilçe, Emre Çakır, Ilhan Hacıbekiroğlu

Online first

Research paper

Angiomatoid fibrous histiocytoma of the spermatic cord — case report and literature review

Krzysztof Kowalik, Mirosław Parafiniuk, Jerzy Grabarek, Andrzej Modrzejewski

Online first

Case report

Comparison of clinical, pathological, and prognostic features of small bowel tumors

Murat Kiraci, Selin Akturk Esen, Fahriye Tugba Kos, Burak Civelek, Dogan Uncu

Online first

Research paper

Adjuvant systemic treatment in luminal breast cancer — what else apart from hormone therapy?

Sylwia Dębska-Szmich, Piotr Potemski

Online first

Review paper

Pleural fluid matrix metalloproteinase-9 levels and cancer ratio as diagnostic tools for malignant pleural effusion

Adlan Pratama Binharyanto, Ngakan Putu Parsama Putra, Sastia Rakhma, Christian Surya Eka Putra

Online first

Research paper

Does radiocolloid remain the gold standard in melanomas? New sentinel lymph node localization techniques

Kinga K. Flisiewicz, Karolina K. Mizera, Maria Szymaniak, Mateusz Wichtowski

Online first

Review paper

Pulmonary pleomorphic carcinoma treated with immune checkpoint inhibitors — a case series

Anna Rudzińska, Karol Jakubik, Jakub Oberda, Mikołaj Jeżak, Eliza Kolasa, Alicja Paluch, Katarzyna Szklener

Online first

Case report

Cancer of an unknown primary with PDZRN3-RAF1 fusion and ATR splice site mutation, with atypical chemosensitivity pattern

Wiktoria Z. Ziółek, Magdalena Ulatowska-Białas, Anna Grochowska, Paweł M. Potocki

Online first

Case report

Safety of combination therapy with olaparib and bevacizumab in the maintenance treatment of a patients with newly diagnosed ovarian cancer

Kaja Michalczyk, Anita M. Chudecka-Głaz

Online first

Review paper

When you can’t see the wood for the trees — rare and not so rare malignancies in Nijmegen breakage syndrome: a review

Jakub P. Czerwik, Dominika M. Janowska, Aleksandra W. Bratborska, Emilia Żurowska

Online first

Review paper

Advances in oncology after the 2024 European Society for Medical Oncology (ESMO) congress

Dawid Sigorski, Małgorzata Osmola, Bartosz Spławski, Sylwia Tabor, Mirosława Püsküllüoğlu, Renata Pacholczak-Madej, Edyta Hunia-Prejsnar, Michał Gola, Michał Wilk, Agnieszka Markiewicz, Joanna Kiszka

Online first

Conference report / Report

Role of radiotherapy to the primary lesion in metastatic non-small cell lung cancer patients after first-line systemic therapy — a prospective randomized phase II study

Ahmed Sohaib, Eman Abdelrazek, Enas El-Khouly, Yostena Mekhail, Reham Ahmed Abdelaziz

Online first

Research paper

T cell immunoglobulin and mucin-domain containing-3 (TIM-3), lymphocyte-activation gene 3 (LAG-3), and T cell immunoreceptor with immunoglobulin and ITIM domain (TIGIT) — an update on emerging negative immune checkpoints in cancer treatment

Natalia Krzyżanowska

Online first

Review paper

Multiple primary malignancies and cancer during pregnancy — a case of two rare consecutive conditions

Izabela Dymanowska, Karolina Frankowska, Natalia Olbrot, Marika Jerzak, Paulina Miciuda, Elżbieta Witt, Grzegorz Polak

Online first

Case report

Optimization of systemic treatment in patients with bladder, ureter, and renal pelvis cancer — expert opinion of the Polish Society of Clinical Oncology

Piotr Wysocki, Maciej Krzakowski, Łukasz Kwinta, Jakub Kucharz, Iwona Skoneczna, Paweł Wiechno

Online first

Guidelines / Expert consensus

Combined immunotherapy in lung cancer — a case report highlighting immune response dynamics and clinical success

Tomasz Jankowski, Natalia Krzyżanowska, Kamila Wojas-Krawczyk, Paweł Krawczyk, Janusz Milanowski

Online first

Case report